fda
Drama atop the FDA
George Tidmarsh, the FDA’s top drug regulator, resigned after the agency’s top biologics regulator accused Tidmarsh of using his position to punish a former business partner with whom Tidmarsh had a falling out, Lizzy Lawrence and Adam Feuerstein report.
Tidmarsh, who had earlier been abruptly placed on leave by Commissioner Marty Makary, denied wrongdoing and accused senior FDA officials — including CBER chief Vinay Prasad — of being in the wrong.
Read all about the beef between Tidmarsh and Prasad and the role of a separate beef, between Tidmarsh and Kevin Tang, a San Diego-based health care investor and business owner, in Tidmarsh’s ouster.
Lizzy and Matthew Herper wrote a follow-up story with more details about the soap opera and commentary from former FDA officials and experts.
And you can get the lowdown on the feud between Prasad and his staff in an exclusive story by Lizzy. Dozens of scientists are considering leaving Prasad’s biologics center, where mistrust and paranoia have taken root.
But wait, there’s more. Andrew Joseph tells us about an explosive lawsuit against Tidmarsh that includes a series of incendiary texts and emails he is said to have sent to Tang.
maha
Deep in the heart of MAHA
Many Texans probably don’t like being compared to Californians, but Isabella Cueto did it anyway.
After a weeklong trip around the state talking with everyday folks, Isa found that although the average Texan might not recognize the Make America Healthy Again movement by name, many embrace its ethos. The state also has become a testing ground for the movement’s odd mix of legislative priorities.
“Really, the nation has just caught up with what we’ve been dealing with in Texas for the past 10 years,” said Rekha Lakshmanan, chief strategic officer for The Immunization Partnership, a nonprofit group that promotes vaccination as a public health strategy.
Isa did a great job on this one. You should read it.
doctors
Medicare cuts pay for surgeries
In a blow to specialists, Medicare on Friday made good on its earlier proposal to cut payments for surgeries, outpatient procedures, and other services it believes can be done more efficiently, Tara Bannow reports.
The policy is both controversial and easy to miss, due to its technical nature, but Tara knows her stuff.
The policy involves a so-called efficiency adjustment, which assumes that advances in technology and standardized workflows reduce the time and expense of performing certain procedures. Medicare will cut pay rates 2.5% for those services starting Jan. 1.
Meanwhile, payments for time-based services that primary care doctors typically provide, such as office visits or behavioral health therapy, will not be cut. Telehealth and certain maternity services will also be unaffected.
Read more.